Failure of neutrophil migration to infectious focus and cardiovascular changes on sepsis in rats: Effects of the inhibition of nitric oxide production, removal of infectious focus, and antimicrobial treatment

Shock

Volumn 25, Issue 3, 2006, Pages 267-276

  Torres Duenas D ^a   Benjamim, C F ^b   Ferreira, S H ^a   Cunha, F Q ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Bacterial dissemination; Infectious focus; Peritoneal lavage; Sulfamethoxazole trimethoprim treatment

Indexed keywords

AMINOGUANIDINE; ANTIBIOTIC AGENT; COTRIMOXAZOLE; CYTOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; NITRATE;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD; CARDIOVASCULAR PERFORMANCE; CARDIOVASCULAR SYSTEM; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; EXPERIMENTAL INFECTION; HYPOTENSION; INFECTIOUS FOCUS; LEUKOCYTE MIGRATION; LIVER; LUNG; MALE; MORTALITY; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PERITONEUM LAVAGE; RAT; SEPSIS; SURVIVAL; ANIMAL; BACTERIAL INFECTION; BLOOD PRESSURE; CECUM; CELL MOTION; ENZYME LINKED IMMUNOSORBENT ASSAY; LEUKOCYTE COUNT; LIGATION; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PUNCTURE; WISTAR RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CECUM; CELL MOVEMENT; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; LEUKOCYTE COUNT; LIGATION; MALE; NEUTROPHILS; NITRATES; PERITONEAL LAVAGE; PUNCTURES; RATS; RATS, WISTAR; SEPSIS;

EID: 33646075732     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000208804.34292.38     Document Type: Article

References (37)

1. Angus DC, Linde-Zwirble WT, Lidicker J: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310, 2001.
2. Shelley O, Murphy T, Paterson H, Mannick JA, Lederer JA: Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury. Shock 20(2):123-129, 2003.
3. Hoesel LM, Neff TA, Neff SB, Younger JG, Olle EW, Gao H, Pianko MJ, Bernacki KD, Sarma JV, Ward PA: Harmful and protective roles of neutrophils in sepsis. Shock 24(1):40-47, 2005.
4. Tavares-Murta BM, Cunha FQ, Ferreira SH: The intravenous administration of tumor necrosis factor alpha, interleukin 8 and macrophage-derived neutrophil chemotactic factor inhibits neutrophil migration by stimulating nitric oxide production. Br J Pharmacol 124(7):1369-1374, 1998.
5. Benjamim CF, Ferreira SH, Cunha FQ: Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis 182:214-223, 2000.
6. Crosara-Alberto DP, Darini ALC, Inoue RY, Silva JS, Ferreira SH, Cunha FQ: Involvement of NO in the failure of neutrophil migration in sepsis induced by Staphylococcus aureus. Br J Pharmacol 136:645-658, 2002.
7. Tavares-Murta BM, Zaparoli M, Ferreira RB, Silva-Vergara ML, Oliveira CH, Murta EF, Ferreira SH, Cunha FQ: Failure of neutrophil chemotactic function in septic patients. Crit Care Med 30(5):1056-1061, 2002.
8. Hickey MJ, Kubes P: Role of nitric oxide in regulation of leukocyte-endothelial cell interactions. Exp Physiol 82:339-348, 1997.
9. Kaplan SS, Lancaster JR, Brasford RE, Simmons RL: Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun 64:69-76, 1996.
10. Dellinger RP, Opal SM, Rotrosen D: From the bench to the bedside: the future of sepsis research. Chest 11:744-753, 1997.
11. Bone RC, Grodzin CJ, Balk RA: Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235-243, 1997.
12. Schein M, Gecelter G, Freinkel W, Gerding H, Becker PJ: Peritoneal lavage in abdominal sepsis. A controlled clinical study. Arch Surg 125:1132-1135, 1990.
13. Lamperi S, Carozzi S: Immunologic patterns in CAPD patients with peritonitis. Clin Nephrol 30(Suppl 1):S41-S44, 1988.
14. Thorounhmam J, Walker L, Collins J: Spreading organisms by peritoneal lavage. Am J Surg 115:339-340, 1968.
15. Michel M, Gutmann L: Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet 349:1901-1906, 1997.
16. Prins JM, Kuijper EDJ, Mevissen MLCM, Speelman P, Van deventer SJH: Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect Immun 2236-2242, June 1995.
17. Wichtermann KA, Baude AE, Chaudry IH: Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
18. Rees GS, Gee CK, Ward HL, Ball C, Tarrant GM, Poole S: Rat tumour necrosis factor-alpha: expression in recombinant Pichia pastoris, purification, characterization and development of a novel ELISA. Eur Cytokine Netw 10(3):383-392, 1999.
19. Souza-Filho RRA, Souza MH, Oliveira SH, Costa CH, Cunha FQ, Ferreira HS: Role of resident mast cells and macrophages in the neutrophil migration induced by LTB4, fMLP and C5a des arg. Int Arch Allergy Immunol 112(1): 27-35, 1997.
20. Souza DG, Cassali GD, Poole S, Teixeira MM: Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol 134:985-994, 2001.
21. Bradley PP, Christensen RD, Rothstein G: Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60:618-622, 1982.
22. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131-138, 1982.
23. Faccioli LH, Souza GEP, Cunha FQ, Poole S, Ferreira SH: Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration - in vivo - by indirect mechanisms. Agents Actions 30(3/4):344-349, 1990.
24. Abraham E: Neutrophils and acute lung injury. Crit Care Med 31:S195-S199, 2003.
25. Walley KR, Lukacs NW, Standiford TJ, Strieter RM, Kunkel SL: Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 64:4733-4738, 1996.
26. Morris SM, Billiar TR: New insights into the regulation of inducible nitric oxide. Am J Physiol 266:E829-E839, 1994.
27. Stuehr DJ, Marletta MA: Mammalian nitrate biosynthesis: mouse macrophages produce nitrate and nitrite in response to E coli lipopolysaccharide. Proc Natl Acad Sci U S A 82:7738-7742, 1985.
28. Landin L, Lorente JA, Renes E, Canas P, Jorge P, Liste D: Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Chest 106:250-256, 1994.
29. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182:591-595, 1990.
30. Vogel SN, Douches SD, Kaufman EN, Neta R: Induction of colony stimulating factor in vivo by recombinant interleukin 1 alpha and recombinant tumor necrosis factor alpha. J Immunol 138:2143-2148, 1987.
31. Benjamim CF, Silva JS, Fortes ZB, Oliveira MA, Ferreira SH, Cunha FQ: Inhibition of leukocyte rolling by nitric oxide during sepsis leads to reduced migration of active microbicidal neutrophils. Infect Immun 70(7):3602-3610, 2002.
32. Parsons PE: Interleukin-10: the ambiguity in sepsis continues. Crit Care Med 26:818-819, 1998.
33. Wolkow PP: Involvement and dual effects of nitric oxide in septic shock. Inflamm Res 47:152-166, 1998.
34. Dal Secco D, Paron JA, De Oliveira SHP, Ferreira SH, Silva JS, Cunha FQ: Neutrophil migration in inflammation: nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide 9:153-164, 2004.
35. Fierro IM, Nascimento-da Silva V, Arruda MAB, Freitas MS, Plotkowski MM, Barja-Fidalgo C: Induction of NOS in rat blood PMN: in vivo and in vitro modulation by tyrosine kinase and involvement in bactericidal activity. J Leukoc Biol 65:508-514, 1999.
36. Bowman MA, Simell OG, Peck AG, Cornelius J, Luchetta R, Look Z, Maclaren NK, Atkinson MA: Pharmacokinetics of aminoguanidine administration and effects on the diabetes frequency in nonobese diabetic mice. J Pharmacol Exp Ther 279(2):790-794, 1996.
37. Zelenitsky S, Iacovidesa H, Ariano RE, Harding Godfrey KM: Antibiotic combinations significantly more active than monotherapy in an in vitro infection model of Stenotrophomonas maltophilia. Diagn Microbiol Infect Dis 51:39-43, 2005.